, Hong Kong

Sennosides drugs recalled

The Department of Health instructed Welfore Co Ltd, to recall four of its sennosides drugs from shelves as market surveillance conducted by DH pharmaceutical inspectors found that a sample failed the disintegration test.

 

The four drugs, Welfore Senna Forte Tab 17mg, Wel Health Strong Senna Tab 17mg , Legend Senna Extra Tab 17mg and Senno Forte Tab 17mg, are actually one and the same pharmaceutical product, manufactured in the United States and imported into Hong Kong for sale over the counter for the relief of constipation. According to the product specifications, the drugs should disintegrate within 30 minutes.

Investigation revealed that since the products were registered with the Pharmacy and Poisons Board, only one shipment has been made.

"Here, contravention of the Public Health and Municipal Services Ordinance, selling a drug not of the nature, substance or quality demanded by the purchaser, might have occurred. The maximum penalty involved is $10,000 and three months' imprisonment," a DH spokesperson said.
 

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Hong Kong and Shanghai to enhance financial ties
The two cities will leverage on their competitive advantage to boost their financial cooperation.
HK Express load factors exceed 97% in April amidst Easter holidays
Current bookings to North Asian destinations exceed 90% occupancy as Golden Week approaches.
Aviation
PolyU partners with ZEISS for myopia control tech advancement
The partnership focuses on developing myopia control and other ophthalmic technologies.
Healthcare